ENDRA Income Before Tax vs Other Operating Expenses Analysis

NDRA Stock  USD 5.71  0.34  5.62%   
ENDRA Life financial indicator trend analysis is much more than just examining ENDRA Life Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ENDRA Life Sciences is a good investment. Please check the relationship between ENDRA Life Income Before Tax and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Income Before Tax vs Other Operating Expenses

Income Before Tax vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ENDRA Life Sciences Income Before Tax account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between ENDRA Life's Income Before Tax and Other Operating Expenses is -0.98. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of ENDRA Life Sciences, assuming nothing else is changed. The correlation between historical values of ENDRA Life's Income Before Tax and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of ENDRA Life Sciences are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Income Before Tax i.e., ENDRA Life's Income Before Tax and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.98
Relationship DirectionNegative 
Relationship StrengthSignificant

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on ENDRA Life income statement and is an important metric when analyzing ENDRA Life Sciences profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ENDRA Life Sciences. It is also known as ENDRA Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from ENDRA Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ENDRA Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At present, ENDRA Life's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 574.37, whereas Selling General Administrative is forecasted to decline to about 3.7 M.
 2023 2024 (projected)
Non Recurring258.8K230.0K
Reconciled Depreciation282.0K180.8K

ENDRA Life fundamental ratios Correlations

0.80.750.990.970.79-0.93-0.80.780.960.310.960.770.370.860.530.740.870.830.680.980.750.74-0.190.83-0.61
0.80.690.770.750.87-0.63-0.790.580.660.270.660.740.360.790.660.580.840.750.70.780.420.78-0.140.75-0.34
0.750.690.660.640.74-0.66-0.660.870.730.240.730.540.270.710.390.470.690.980.570.750.420.65-0.150.66-0.41
0.990.770.660.980.75-0.94-0.780.730.950.310.950.760.370.840.530.740.850.740.650.970.760.71-0.180.8-0.64
0.970.750.640.980.72-0.89-0.820.690.90.410.90.80.470.870.590.70.90.720.750.910.730.77-0.240.77-0.65
0.790.870.740.750.72-0.62-0.780.610.670.290.670.750.360.790.60.740.820.830.780.770.650.88-0.150.9-0.07
-0.93-0.63-0.66-0.94-0.89-0.620.55-0.8-0.98-0.05-0.98-0.53-0.09-0.67-0.22-0.66-0.66-0.72-0.43-0.96-0.73-0.51-0.04-0.720.66
-0.8-0.79-0.66-0.78-0.82-0.780.55-0.54-0.64-0.76-0.64-0.97-0.81-0.98-0.9-0.49-0.95-0.73-0.9-0.69-0.53-0.890.62-0.740.43
0.780.580.870.730.690.61-0.8-0.540.830.170.830.390.180.630.230.40.580.850.440.790.40.51-0.110.56-0.61
0.960.660.730.950.90.67-0.98-0.640.830.171.00.620.210.750.310.660.70.790.480.980.760.56-0.10.77-0.65
0.310.270.240.310.410.29-0.05-0.760.170.170.170.730.990.70.820.040.570.260.670.160.170.56-0.940.26-0.3
0.960.660.730.950.90.67-0.98-0.640.831.00.170.620.210.750.310.660.70.790.480.980.760.56-0.10.77-0.65
0.770.740.540.760.80.75-0.53-0.970.390.620.730.620.790.950.880.540.910.640.840.670.640.83-0.610.78-0.35
0.370.360.270.370.470.36-0.09-0.810.180.210.990.210.790.740.890.120.640.30.710.220.20.61-0.920.3-0.33
0.860.790.710.840.870.79-0.67-0.980.630.750.70.750.950.740.80.50.930.780.850.780.630.85-0.570.81-0.49
0.530.660.390.530.590.6-0.22-0.90.230.310.820.310.880.890.80.350.780.440.780.410.250.74-0.720.47-0.3
0.740.580.470.740.70.74-0.66-0.490.40.660.040.660.540.120.50.350.590.560.510.750.760.610.070.67-0.11
0.870.840.690.850.90.82-0.66-0.950.580.70.570.70.910.640.930.780.590.760.930.760.590.94-0.350.79-0.45
0.830.750.980.740.720.83-0.72-0.730.850.790.260.790.640.30.780.440.560.760.640.820.560.73-0.150.79-0.36
0.680.70.570.650.750.78-0.43-0.90.440.480.670.480.840.710.850.780.510.930.640.530.490.98-0.420.69-0.21
0.980.780.750.970.910.77-0.96-0.690.790.980.160.980.670.220.780.410.750.760.820.530.750.62-0.080.81-0.58
0.750.420.420.760.730.65-0.73-0.530.40.760.170.760.640.20.630.250.760.590.560.490.750.56-0.090.85-0.15
0.740.780.650.710.770.88-0.51-0.890.510.560.560.560.830.610.850.740.610.940.730.980.620.56-0.320.78-0.17
-0.19-0.14-0.15-0.18-0.24-0.15-0.040.62-0.11-0.1-0.94-0.1-0.61-0.92-0.57-0.720.07-0.35-0.15-0.42-0.08-0.09-0.32-0.140.27
0.830.750.660.80.770.9-0.72-0.740.560.770.260.770.780.30.810.470.670.790.790.690.810.850.78-0.14-0.13
-0.61-0.34-0.41-0.64-0.65-0.070.660.43-0.61-0.65-0.3-0.65-0.35-0.33-0.49-0.3-0.11-0.45-0.36-0.21-0.58-0.15-0.170.27-0.13
Click cells to compare fundamentals

ENDRA Life Account Relationship Matchups

ENDRA Life fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets7.2M8.8M12.9M9.3M6.8M6.6M
Other Current Liab430.1K430.8K488.1K909.1K340.4K357.6K
Total Current Liabilities2.1M986.7K1.5M1.7M903.1K1.2M
Total Stockholder Equity4.8M7.2M10.8M7.2M5.7M5.2M
Net Tangible Assets4.8M7.2M10.8M7.2M8.3M5.1M
Property Plant And Equipment Net641.2K551.3K774.5K741.5K465.9K510.7K
Net Debt(5.5M)(6.5M)(8.8M)(4.3M)(2.4M)(2.6M)
Retained Earnings(45.2M)(57.3M)(68.7M)(81.9M)(91.9M)(87.3M)
Accounts Payable1.3M402.9K791.1K614.0K360.4K569.7K
Cash6.2M7.2M9.5M4.9M2.8M4.7M
Non Current Assets Total641.2K551.3K780.5K747.5K3.7M3.9M
Cash And Short Term Investments6.2M7.2M9.5M4.9M2.8M4.7M
Common Stock Total Equity392.0742.0842.03.4K3.9K4.1K
Common Stock Shares Outstanding375.0K959.6K2.0M2.9M9.0M9.5M
Liabilities And Stockholders Equity7.2M8.8M12.9M9.3M6.8M6.6M
Capital Surpluse23.2M33.9M49.9M64.5M74.2M77.9M
Inventory113.4K589.6K1.3M2.6M2.6M2.8M
Other Current Assets130.7K396.8K2.7M992.9K198.9K189.0K
Other Stockholder Equity49.9M64.5M79.5M89.1M97.6M51.6M
Total Liab2.4M1.6M2.1M2.1M1.1M1.4M
Property Plant And Equipment Gross641.2K551.3K774.5K741.5K1.1M576.8K
Total Current Assets6.5M8.2M12.1M8.5M3.0M5.7M
Accumulated Other Comprehensive Income43.5K10.8K13.9K6.1K5.2K5.5K
Common Stock842.03.4K4.3K317.01.0K1.3K
Property Plant Equipment641.2K551.3K774.5K741.5K852.7K510.5K
Net Receivables116.7K390.8K(1.3M)(2.6M)(2.4M)(2.2M)
Non Current Liabilities Total342.8K609.0K546.6K365.9K192.1K251.3K
Short Long Term Debt Total707.1K685.5K679.0K546.6K394.4K452.9K
Short Term Debt364.3K153.0K264.7K180.7K202.3K211.5K
Net Invested Capital5.1M7.5M10.8M7.2M5.7M7.5M
Net Working Capital4.5M7.2M10.6M6.8M2.1M2.0M
Capital Stock843.03.4K4.3K318.01.0K1.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.